The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.57

Today's change-0.31 -2.23%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.57

Today's change-0.31 -2.23%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc crosses below 200-day moving average

Allscripts Healthcare Solutions Inc closed sharply lower Thursday, dropping (U.S.)$0.31 or 2.23% to (U.S.)$13.57 and crossing below its 200-day moving average. Over the last five days, shares have lost 2.23% and are down 11.77% for the last year to date. This security has outperformed the S&P 500 by 4.10% during the last year.

Key company metrics

  • Open(U.S.) $13.87
  • Previous close(U.S.) $13.88
  • High(U.S.) $13.87
  • Low(U.S.) $13.55
  • Bid / Ask(U.S.) $11.30 / (U.S.) $0.00
  • YTD % change-11.77%
  • Volume1,380,274
  • Average volume (10-day)1,240,837
  • Average volume (1-month)1,951,082
  • Average volume (3-month)2,549,823
  • 52-week range(U.S.) $11.47 to (U.S.) $15.78
  • Beta1.02
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward23.98×
  • Forward PEG1.55×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.02
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.01%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue346354352335
Total other revenue--------
Total revenue346354352335
Gross profit154153144130
Total cost of revenue192201208205
Total operating expense323346346340
Selling / general / administrative79918782
Research & development46484447
Depreciation / amortization4677
Interest expense (income), net operating--------
Unusual expense (income)1000
Other operating expenses, total--------
Operating income2396-6
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax15-1-2-11
Income after tax16-5-3-10
Income tax, total-241-1
Net income16-5-3-10
Total adjustments to net income--------
Net income before extra. items16-5-3-10
Minority interest000--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items16-5-3-10
Inc. avail. to common incl. extra. items16-5-3-10
Diluted net income16-5-3-10
Dilution adjustment--------
Diluted weighted average shares189189182181
Diluted EPS excluding extraordinary itemsvalue per share0.09-0.03-0.02-0.06
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.09-0.03-0.02-0.06